Close

More on PFE

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-58.5% Growth)
- Ratings (4.1 Score)
- Holders
- Dividends (6.4% Yield)
- Event Driven Deals
- FDA Archive

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (5/1/24)
- M&A (N/A)
- M&A (N/A)
- M&A (6/30/20 *Est)
- M&A (3/31/23 *Est)
- M&A (12/31/23 *Est)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

PFE Cash Flow Statement

Click line-items for a historical chart and %
Operating Activities:
Net income before allocation to noncontrolling interests 6.38B
Adjustments to reconcile net income before allocation to noncontrolling interests to net cash provided by/(used in) operating activities:
Depreciation and amortization
Share-based compensation expense 532M
Asset write-offs and impairment charges
Acquisition-related in-process research and development charges
Deferred taxes from continuing operations -1.34B
Other non-cash adjustments 68M
Benefit plan contributions (in excess of)/less than expense
Other changes in assets and liabilities, net of acquisitions and divestitures -1.72B
Net cash provided by/(used in) operating activities 9.93B
Investing Activities:
Purchases of property, plant and equipment -1.13B
Purchases of short-term investments -15.17B
Proceeds from redemptions and sales of short-term investments--net 20.69B
Purchases of long-term investments -4.77B
Proceeds from redemptions and sales of long-term investments 6.92B
Acquisitions, net of cash acquired -17.68B
Other investing activities 60M
Net cash provided by investing activities -4.7B
Financing Activities:
Increase in short-term borrowings
Principal payments on short-term borrowings--net
Principal payments on long-term debt -4.32B
Purchases of common stock -5B
Cash dividends paid -5.5B
Other financing activities 29M
Net cash used in financing activities -6.69B
Effect of exchange-rate changes on cash and cash equivalents -79M
Net increase/(decrease) in cash and cash equivalents -1.55B
Cash and cash equivalents at beginning of period 3.64B
Cash and cash equivalents at end of period 2.09B
Supplemental Cash Flow Information:
Cash paid for income taxes 1.43B
Cash paid for interest

Entities mentioned with PFE

View All Entities